We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
10 hedge funds and large institutions have $33.1M invested in ESSA Pharma in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
40% more capital invested
Capital invested by funds: $23.6M → $33.1M (+$9.51M)
0% more funds holding
Funds holding: 10 → 10 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.02% less ownership
Funds ownership: 1.9% → 1.88% (-0.02%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
10
Holders Change
–
Holders Change %
0%
% of All Funds
0.25%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
1
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$143 |
Top Sellers
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$289K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.3K |